BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17003937)

  • 1. Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs.
    Tagliaferri A; Rivolta GF; Rossetti G; Pattacini C; Gandini G; Franchini M
    Thromb Haemost; 2006 Oct; 96(4):542-3. PubMed ID: 17003937
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis in people with haemophilia.
    Coppola A; Franchini M; Tagliaferri A
    Thromb Haemost; 2009 Apr; 101(4):674-81. PubMed ID: 19350110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the benefits of prophylaxis in the management of hemophilia A.
    Hoots WK; Nugent DJ
    Thromb Haemost; 2006 Oct; 96(4):433-40. PubMed ID: 17003919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
    den Uijl IE; Fischer K
    Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran.
    Daliri AA; Haghparast H; Mamikhani J
    Int J Technol Assess Health Care; 2009 Oct; 25(4):584-7. PubMed ID: 19845990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis in adults with haemophilia.
    Hay CR
    Haemophilia; 2007 Sep; 13 Suppl 2():10-5. PubMed ID: 17685918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs.
    Tagliaferri A; Franchini M; Coppola A; Rivolta GF; Santoro C; Rossetti G; Feola G; Zanon E; Dragani A; Iannaccaro P; Radossi P; Mannucci PM
    Haemophilia; 2008 Sep; 14(5):945-51. PubMed ID: 18540895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.
    Collins PW; Björkman S; Fischer K; Blanchette V; Oh M; Schroth P; Fritsch S; Casey K; Spotts G; Ewenstein BM
    J Thromb Haemost; 2010 Feb; 8(2):269-75. PubMed ID: 19943875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awaiting evidence-based recommendations on prophylaxis in adult patients.
    Tagliaferri A
    Haemophilia; 2010 Nov; 16(6):955-6. PubMed ID: 20579114
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of arthropathy in haemophilia: prophylaxis.
    Santagostino E; Mancuso ME
    Haemophilia; 2008 Nov; 14 Suppl 6():16-9. PubMed ID: 19134028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing outcomes for patients with severe haemophilia A.
    Pipe SW; Valentino LA
    Haemophilia; 2007 Nov; 13 Suppl 4():1-16; quiz 3 p following 16. PubMed ID: 17822512
    [No Abstract]   [Full Text] [Related]  

  • 14. The parachute must be properly folded ..
    Donfield SM; Shapiro AD; Gomperts ED; Lynn HS; Usner DW
    J Thromb Haemost; 2007 Mar; 5(3):646-7. PubMed ID: 17092299
    [No Abstract]   [Full Text] [Related]  

  • 15. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH.
    Fischer K; Collins PW; Ozelo MC; Srivastava A; Young G; Blanchette VS
    J Thromb Haemost; 2016 May; 14(5):1105-9. PubMed ID: 27186714
    [No Abstract]   [Full Text] [Related]  

  • 16. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
    Petrini P
    Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis for hemophilia: state of the art or state of confusion?
    Gruppo RA
    J Pediatr; 1998 Jun; 132(6):915-7. PubMed ID: 9627577
    [No Abstract]   [Full Text] [Related]  

  • 18. Some aspects on the management of hemophilia.
    Aledort LM
    Thromb Haemost; 1995 Jul; 74(1):440-3. PubMed ID: 8578502
    [No Abstract]   [Full Text] [Related]  

  • 19. An approach to target joint bleeding in hemophilia: prophylaxis for all or individualized treatment?
    Abshire T
    J Pediatr; 2004 Nov; 145(5):581-3. PubMed ID: 15520752
    [No Abstract]   [Full Text] [Related]  

  • 20. To bleed or not to bleed - is that a question?
    Aledort LM
    J Thromb Haemost; 2010 Jan; 8(1):81-2. PubMed ID: 19874456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.